Guerbet SA (EPA:GBT)
17.56
-0.46 (-2.55%)
At close: Nov 28, 2025
Guerbet Market Cap
Guerbet has a market cap or net worth of €221.28 million as of November 28, 2025. Its market cap has decreased by -33.78% in one year.
Market Cap
221.28M
Enterprise Value
568.25M
Revenue
820.92M
Ranking
n/a
PE Ratio
28.60
Stock Price
€17.56
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has increased from 142.85M to 221.28M, an increase of 54.91%. That is a compound annual growth rate of 1.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 221.28M | -34.52% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | 413.32M | -20.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 20.17B |
| bioMérieux | 12.74B |
| Eurofins Scientific SE | 10.40B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.08B |